Clinical Trial Update: DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

View source ↗

Summary

DECAMP 1 PLUS is investigating noninvasive biomarkers to predict lung cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Boston University | Conditions: Pulmonary Disease | Status: ACTIVE_NOT_RECRUITING